Diageo PLC (DGE.L)
(The following statement was released by the rating agency) NEW YORK, September 20 (Fitch) Fitch Ratings has affirmed Brown-Forman Corporation's (Brown-Forman) ratings including the Long-Term Issuer Default Rating (IDR) at 'A' and Short-Term IDR at 'F1'. The Rating Outlook has been revised to Stable from Negative. A full list of ratings follows at the end of this release. Brown-Forman's affirmation and Outlook revision to Stable reflects an improving financial profile due to expectations for dec
Diageo, the maker of Johnnie Walker whisky and Smirnoff vodka, forecast stronger sales and profit growth in the second half of its financial year after a first half affected by negative factors in China and India and higher spending.
Sept 20 Diageo, the maker of Johnnie Walker whisky and Smirnoff vodka, forecast stronger sales and profit growth in the second half of its financial year after a first half affected by negative factors in China and India and higher spending.
Sept 20 Britain's Diageo, the maker of Johnnie Walker whisky and Smirnoff vodka, said it expects its organic first-half sales growth to be impacted by the timing of Chinese New Year and a ban on selling alcohol along highways in India.
* ON 26 JULY 2017, BOARD OF DIAGEO PLC APPROVED A SHARE BUY-BACK PROGRAMME TO RETURN UP TO £1.5 BILLION TO SHAREHOLDERS DURING FISCAL YEAR ENDING 30 JUNE 2018
LONDON, Aug 11 One of Diageo's largest shareholders has questioned its decision to sell one of its oldest whiskey brands while buying a tequila company founded by actor George Clooney.
LONDON, Aug 2 The prospect of higher interest rates and stronger global growth is tempting investors away from the richly-valued shares and relative safety of some of Europe's largest consumer-focused players, leaving these vulnerable.
NAIROBI, July 27 Kenya's East African Breweries said net profit for the year through June rose 6 percent to 8.5 billion Kenyan shillings ($81.89 million), helped by reduced operating costs and a slight rise in sales.
* Shares jump more than 6 pct to record high (Adds analyst comment, background)
LONDON, July 27 A punishing fall in AstraZeneca's shares after the failure of a key lung cancer study for the pharma company offset the impact of earnings-led gains for drinks giant Diageo on Britain's top share index.